HealthEquity, Inc. $HQY Shares Acquired by Inspirion Wealth Advisors LLC

Inspirion Wealth Advisors LLC increased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 15.4% in the third quarter, Holdings Channel reports. The firm owned 75,005 shares of the company’s stock after buying an additional 10,005 shares during the quarter. HealthEquity accounts for 1.0% of Inspirion Wealth Advisors LLC’s investment portfolio, making the stock its 18th biggest holding. Inspirion Wealth Advisors LLC’s holdings in HealthEquity were worth $7,108,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently modified their holdings of the company. Corient Private Wealth LLC acquired a new stake in shares of HealthEquity in the 2nd quarter worth $515,000. Osaic Holdings Inc. lifted its holdings in shares of HealthEquity by 2.2% in the second quarter. Osaic Holdings Inc. now owns 12,441 shares of the company’s stock valued at $1,284,000 after purchasing an additional 273 shares in the last quarter. Orion Porfolio Solutions LLC grew its holdings in HealthEquity by 14.9% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 3,770 shares of the company’s stock valued at $395,000 after buying an additional 490 shares during the last quarter. Squarepoint Ops LLC grew its holdings in shares of HealthEquity by 172.1% during the second quarter. Squarepoint Ops LLC now owns 35,142 shares of the company’s stock worth $3,681,000 after buying an additional 22,229 shares in the last quarter. Finally, Cim Investment Management Inc. lifted its stake in shares of HealthEquity by 100.5% during the 2nd quarter. Cim Investment Management Inc. now owns 7,834 shares of the company’s stock worth $786,000 after purchasing an additional 3,927 shares during the period. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on HQY shares. Citizens Jmp increased their price objective on shares of HealthEquity from $117.00 to $122.00 and gave the stock a “market outperform” rating in a research report on Thursday, December 4th. JPMorgan Chase & Co. boosted their price target on shares of HealthEquity from $126.00 to $129.00 and gave the company an “overweight” rating in a report on Thursday, December 4th. Barrington Research reiterated an “outperform” rating and issued a $125.00 price objective on shares of HealthEquity in a report on Thursday, December 4th. BTIG Research reaffirmed a “buy” rating and set a $130.00 target price on shares of HealthEquity in a report on Thursday, December 4th. Finally, Barclays started coverage on shares of HealthEquity in a research note on Monday, December 8th. They set an “overweight” rating and a $118.00 price objective for the company. Two investment analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, HealthEquity currently has an average rating of “Moderate Buy” and a consensus target price of $120.27.

HealthEquity Stock Down 1.1%

Shares of HQY opened at $95.75 on Tuesday. The company has a 50-day simple moving average of $96.86 and a 200-day simple moving average of $96.59. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. HealthEquity, Inc. has a 52 week low of $74.07 and a 52 week high of $116.65. The firm has a market capitalization of $8.18 billion, a P/E ratio of 43.92, a P/E/G ratio of 1.40 and a beta of 0.18.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The firm had revenue of $322.16 million during the quarter, compared to analyst estimates of $320.92 million. During the same quarter in the prior year, the business posted $0.78 earnings per share. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, equities research analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insider Activity

In other HealthEquity news, EVP Delano Ladd sold 1,500 shares of HealthEquity stock in a transaction on Thursday, November 20th. The shares were sold at an average price of $104.56, for a total transaction of $156,840.00. Following the completion of the sale, the executive vice president owned 75,479 shares of the company’s stock, valued at approximately $7,892,084.24. The trade was a 1.95% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael Henry Fiore sold 1,781 shares of the company’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the sale, the executive vice president owned 49,795 shares of the company’s stock, valued at $4,392,416.95. This represents a 3.45% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 10,781 shares of company stock valued at $1,016,707 in the last 90 days. Corporate insiders own 1.50% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.